This observational study assessed menopausal symptoms and treatment use in 169 postmenopausal breast cancer survivors, revealing that 62.3% experienced hot flushes, but only 26.6% used treatments. Aromatase inhibitor users reported more sexual dysfunction. Barriers to treatment included fear of recurrence, lack of symptoms, and medical advice. This highlights gaps in
